by NMSGroup | Aug 22, 2024 | 2024, News
Thrilled to announce that our latest paper, in collaboration with Prof. Gian Cesare Tron from Università del Piemonte Orientale (UPO), has just been published in the prestigious “Chemistry – A European Journal”! You can check it out here: link. This publication...
by NMSGroup | Aug 2, 2024 | 2024, Events
We are speaking at the 3rd GLOBAL XDC INNOVATION CONFERENCE in WuXi (CHINA) partnering event in WuXi (CHINA) , 10 – 12 Sep. 2024 We look forward to your presence to explore future partnership opportunities. * * * * * Contact: Valsasina Barbara :...
by NMSGroup | May 28, 2024 | 2024, News
NERVIANO, 28, May 2024_Nerviano Medical Sciences S.r.l. (NMS), a wholly owned subsidiary of NMS Group S.p.A, focused on the discovery and development of oncology drugs and the largest oncological R&D company in Italy, announced, following the shareholder...
by NMSGroup | Apr 22, 2024 | 2024, Events
We are presenting at the SWISS BIOTECH DAY 2024 partnering event in Basel, 22 April, 17.30-17.45 CEST Antonella Isacchi, Head of External Innovation Portfolio, Nerviano Medical Sciences Srl will present the Company and Nerviano Bio-Park at the #SwissBiotechDay on 22...
by NMSGroup | Apr 12, 2024 | 2024, Events
We are attending the SWISS BIOTECH DAY 2024 partnering event in Basel, Switzerland. Nerviano Medical Sciences and the NMS Group affiliates Accelera and NerPharMa, will participate to the SWISS BIOTECH DAY 2024 partnering event, which will be held in the Congress...
Recent Comments